Literature DB >> 12358938

Thalidomide treatment of relapsed multiple myeloma patients and changes in circulating VEGF and bFGF.

V Pittini, D Teti, C Arrigo, G Aloi, M Righi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12358938     DOI： 10.1046/j.1365-2141.2002.37694.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.

Authors:  George Somlo; Ashkan Lashkari; William Bellamy; Todd M Zimmerman; Joseph M Tuscano; Margaret R O'Donnell; Ann F Mohrbacher; Stephen J Forman; Paul Frankel; Helen X Chen; James H Doroshow; David R Gandara
Journal:  Br J Haematol       Date:  2011-04-26       Impact factor: 6.998
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.